| Gene symbol | CTLA4 | Synonyms | ALPS5, CD, CD152, CELIAC3, CTLA-4, GRD4, GSE, IDDM12 | Type of gene | protein-coding |
| Chromosome | 2 | Map location | 2q33.2 | dbXrefs | |
| Gene perturbation-related omics dataset | PertOrg | ||||
| Description | cytotoxic T-lymphocyte associated protein 4 | ||||
| GTO ID | GTC3613 |
| Trial ID | NCT06072989 |
| Disease | Solid Tumor |
| Altered gene | CTLA4 |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-T cell |
| Treatment | B4T2-001 CAR-T cells |
| Phase | Phase1 |
| Recruitment status | Recruiting |
| Title | A Single Arm, Open Label Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Antitumor Activity of B4T2-001 CAR-T in Patients With Advanced Solid Tumors |
| Year | 2023 |
| Country | China |
| Company sponsor | Shanghai East Hospital |
| Other ID(s) | B4T2-PRC IIT-001 |
| Cohort 1 | |||||||
|
|||||||